⌘K

Login Start Free

Home/Filings/4/0000899243-21-008265

4//SEC Filing

Zajic Micah 4

Accession 0000899243-21-008265

CIK 0001604477other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:57 PM ET

Size

5.4 KB

Accession

0000899243-21-008265

Insider Transaction Report

Form 4

Period: 2021-02-23

SQZ Biotechnologies CoSQZ

Chief Business Officer

Transactions

Award
Stock Option
2021-02-23+22,339→ 22,339 total
Exercise: $16.85Exp: 2031-02-22→ Common Stock (22,339 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable as to 25% of the underlying securities on February 23, 2022 and in 36 substantially equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SQZ Biotechnologies Co

CIK 0001604477

Entity typeother

Related Parties

1

filerCIK 0001829046

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 5:57 PM ET
Size: 5.4 KB

View on SEC.gov